Heart Test Laboratories-CW27HSCSWPreferred / convertible
13F holders, Q3 2024 (September 30)3holders −2
0new positions
2sold out
1famous investor
$0.04avg. 13F price*
At the end of Q3 2024, 3 institutions reported holding Heart Test Laboratories-CW27 (HSCSW) in their 13F filings, down 2 from Q2 2024. 0 opened new positions and 2 sold out. The largest holders were Clear Street LLC ($12K), Citadel Advisors ($10K) and Susquehanna International Group, LLP ($2K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Heart Test Laboratories-CW27
- CUSIP
- 42254E112
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $143 |
All 13F filers, Q2 2024 → Q3 2024: 7,865 shares bought and 8,126 shares sold, net −261 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Clear Street LLC | — | No change | 269,879 | $12K |
| Citadel Advisors | — | Reduce -1.7% | 220,428 | $10K |
| Susquehanna International Group, LLP | — | Add +25.4% | 38,824 | $2K |
"% of holder's portfolio" is HSCSW's weight in each manager's 13F, not the share of Heart Test Laboratories-CW27 the manager owns.